TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33516726

Group type: EXPERIMENTAL
Intervention: Lavender essential oil
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 150
Study: 33483440

Group type: EXPERIMENTAL
Intervention: Thoughts and Health programme (12 week course)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Control group (comparable group of children)
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Thoughts and Health programme
Number of subjects: 617
Study: 616173846

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TR) 70 mg/d bid for 3 months, then Ranolazine (RN) 1000 mg/d bid for 3 months
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Ranolazine (RN) 1000 mg/d bid for 3 months, then Trimetazidine (TR) 70 mg/d bid for 3 months
Number of subjects: 276
Study: 35552080

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Shower
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine labor care
Number of subjects: 120
Study: 34564022

Group type: EXPERIMENTAL
Intervention: 600 mg/kg betaine (group B)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 1,200 mg/kg betaine (group C)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 1,800 mg/kg betaine (group D)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 2,400 mg/kg betaine (group E)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Dietary betaine (all groups)
Number of subjects: 300

Group type: COMPARATOR
Intervention: 0 mg/kg betaine (group A)
Number of subjects: 300
Study: 34351386

Group type: EXPERIMENTAL
Intervention: VYC-15L
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 32518952

Group type: EXPERIMENTAL
Intervention: First-line ibrutinib
Number of subjects: 0
Study: 34702168

Group type: EXPERIMENTAL
Intervention: Personalized multicomponent exercise program (8-week program including tailored exercises for upper/lower body, flexibility, strength, and balance)
Number of subjects: 300

Group type: COMPARATOR
Intervention: WHO exercise guidelines (active-control group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 300
Study: 34672473

Group type: EXPERIMENTAL
Intervention: 0.5% timolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (glycerin)
Number of subjects: 40
Study: 32248355

Group type: EXPERIMENTAL
Intervention: Circumferential Heller myotomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laparoscopic Heller myotomy with Dor fundoplication (Control)
Number of subjects: 20
Study: 613264089

Group type: EXPERIMENTAL
Intervention: Theater Alive
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: NUT + MEF + MEM + ML
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 178
Study: 35101116

Group type: EXPERIMENTAL
Intervention: DUDE conducted by trained clinical psychologists (N = 800; 4 schools)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: DUDE conducted by trained teachers (N = 800; 4 schools)
Number of subjects: 3200

Group type: COMPARATOR
Intervention: Minimal intervention 'Stress-free through the school day' (active control group, N = 1600; 8 schools)
Number of subjects: 3200
Study: 33902551

Group type: EXPERIMENTAL
Intervention: SA (alumina sandblasted and acid‐etched) implants
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: NH (bioabsorbable apatite nanocoating) implants
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: SLA (large‐grit sandblasted and acid‐etched) implants
Number of subjects: 75
Study: 33217396

Group type: EXPERIMENTAL
Intervention: PRBC transfusion
Number of subjects: 1660

Group type: COMPARATOR
Intervention: No PRBC transfusion
Number of subjects: 1660
Study: 32273317

Group type: EXPERIMENTAL
Intervention: Group-based lifestyle interventions
Number of subjects: 180

Group type: COMPARATOR
Intervention: Text messages containing health information
Number of subjects: 180
Study: 35139816

Group type: EXPERIMENTAL
Intervention: fremanezumab quarterly
Number of subjects: 928

Group type: EXPERIMENTAL
Intervention: fremanezumab monthly
Number of subjects: 928

Group type: EXPERIMENTAL
Intervention: fremanezumab (total)
Number of subjects: 928

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 928
Study: 34516557

Group type: EXPERIMENTAL
Intervention: Microclinic intervention
Number of subjects: 304
Study: 34200618

Group type: EXPERIMENTAL
Intervention: Resistance exercise with heavy loads
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resistance exercise with light/moderate load
Number of subjects: 10
Study: 32311763

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lopinavir and ritonavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lopinavir and ritonavir + interferon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroquine or hydroxychloroquine
Number of subjects: 0
Study: 34788900

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Number of subjects: 112

Group type: COMPARATOR
Intervention: Bipolar transurethral resection of the prostate
Number of subjects: 112
Study: 33906842

Group type: EXPERIMENTAL
Intervention: C‐F NDS use (combustion-free nicotine delivery systems)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Referral to smoking cessation programmes
Number of subjects: 576
Study: 36169608

Group type: COMPARATOR
Intervention: Control Group 1: diprospan combined with mucopolysaccharide polysulphate cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control Group 2: isotopic phosphorus‐32 dressing combined with mucopolysaccharide polysulphate cream
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Treatment Group: isotopic phosphorus‐32 dressing combined with diprospan and mucopolysaccharide polysulphate cream
Number of subjects: 80
Study: 35256232

Group type: EXPERIMENTAL
Intervention: Ezetimibe plus lifestyle and dietary intervention (eze)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lifestyle and dietary intervention alone (placebo)
Number of subjects: 40
Study: 33306562

Group type: EXPERIMENTAL
Intervention: Peer change agent type I network intervention, including an opinion leader workshop with telephonic booster sessions.
Number of subjects: 423

Group type: COMPARATOR
Intervention: Control group (time-matched control).
Number of subjects: 423
Study: 32401733

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-NPWT treatment (petrolatum gauze and Bogota bag)
Number of subjects: 60
Study: 616875726

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial and peripheral magnetic stimulation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo repetitive transcranial and peripheral magnetic stimulation
Number of subjects: 74
Study: 35997729

Group type: EXPERIMENTAL
Intervention: IMRT alone (n=172)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (IMRT with cisplatin, 100 mg/m2 every 3 weeks for 3 cycles) (n=169)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (n=169)
Number of subjects: 341
Study: 33965518

Group type: EXPERIMENTAL
Intervention: Predictive Parenting
Number of subjects: 62

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 62
Study: 32252725

Group type: EXPERIMENTAL
Intervention: Modified fixation group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional fixation group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 34346273

Group type: EXPERIMENTAL
Intervention: WBV plus hip-knee strengthening (WHK group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: hip-knee strengthening only (HK group)
Number of subjects: 36
Study: 34930386

Group type: EXPERIMENTAL
Intervention: Posttreatment CA-125 level > 10 U/ml
Number of subjects: 97

Group type: COMPARATOR
Intervention: Posttreatment CA-125 level ≤ 10 U/ml
Number of subjects: 97
Study: 33616188

Group type: EXPERIMENTAL
Intervention: Integrated collaborative care
Number of subjects: 409

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 409
Study: 32503520

Group type: EXPERIMENTAL
Intervention: Group A (less than 10% 25-OHD)
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Group B (between 10% and 90% 25-OHD)
Number of subjects: 1232

Group type: EXPERIMENTAL
Intervention: Group C (greater than 90% 25-OHD)
Number of subjects: 1232
Study: 35964621

Group type: EXPERIMENTAL
Intervention: CT-based follow-up (clinic visits, chest x-rays, thoraco-abdominal CT scans, and fibre-optic bronchoscopy for non-adenocarcinoma histology)
Number of subjects: 1775

Group type: COMPARATOR
Intervention: Minimal follow-up (visits and chest x-rays)
Number of subjects: 1775
Study: 33662051

Group type: EXPERIMENTAL
Intervention: Intraoral optical scanning (IOS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional impressions (polyether)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Overall restoration survival rate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Technical complications
Number of subjects: 38
Study: 35256046

Group type: EXPERIMENTAL
Intervention: Continuous thoracic paravertebral block with ropivacaine
Number of subjects: 76

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 76
Study: 32937634

Group type: EXPERIMENTAL
Intervention: Tourniquet
Number of subjects: 81

Group type: COMPARATOR
Intervention: Non-Tourniquet
Number of subjects: 81
Study: 32749579

Group type: EXPERIMENTAL
Intervention: Carbonated water (250 ml)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Plain water (250 ml)
Number of subjects: 1000
Study: 35659319

Group type: EXPERIMENTAL
Intervention: Alkasite-based resin composite (Cention N, Ivoclar Vivadent)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Resin-modified glass ionomer cement (Voco GmbH)
Number of subjects: 40
Study: 33736533

Group type: EXPERIMENTAL
Intervention: Paracetamol dispersible tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paracetamol syrup
Number of subjects: 0
Study: 32485640

Group type: EXPERIMENTAL
Intervention: Deep convolutional neural network of ultrasound (DCNN-US)
Number of subjects: 2143
Study: 36181584

Group type: EXPERIMENTAL
Intervention: StroVac (3 single intramuscular injections every two weeks)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: StroVac
Number of subjects: 376
Study: 33069319

Group type: EXPERIMENTAL
Intervention: Very Brief Exposure (VBE) - repeated presentation of masked phobic stimuli (spiders)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control intervention (masked flowers) - Very Brief Exposure (VBF)
Number of subjects: 82
Study: 34259895

Group type: EXPERIMENTAL
Intervention: Modified autologous fascial sling technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xenograft
Number of subjects: 0
Study: 33241323

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT/A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32238795

Group type: EXPERIMENTAL
Intervention: EUROACTION intervention (nurse-managed comprehensive cardiovascular disease prevention program)
Number of subjects: 1339

Group type: EXPERIMENTAL
Intervention: EUROACTION intervention
Number of subjects: 1339

Group type: COMPARATOR
Intervention: usual care (UC)
Number of subjects: 1339
Study: 35488868

Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) for 24 hours at 33±1°C
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) for 48 hours at 33±1°C
Number of subjects: 65
Study: 33793590

Group type: EXPERIMENTAL
Intervention: Factors influencing market participation
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Price, herd size, off-farm income, distance to market, age of the farmer, cattle fattening, membership in cooperatives, access to market information, farming experience
Number of subjects: 393
Study: 34240125

Group type: EXPERIMENTAL
Intervention: hs‐cTnI at 10 ng/L
Number of subjects: 19501

Group type: EXPERIMENTAL
Intervention: hs‐cTnT at 10 ng/L
Number of subjects: 19501
Study: 32053149

Group type: EXPERIMENTAL
Intervention: Castration plus docetaxel, 75 mg/m2, every 3 weeks for 6 cycles
Number of subjects: 475

Group type: COMPARATOR
Intervention: Castration alone
Number of subjects: 475
Study: 34000870

Group type: EXPERIMENTAL
Intervention: Information sheet written in first-person narrative
Number of subjects: 322

Group type: COMPARATOR
Intervention: Non-narrative information sheet
Number of subjects: 322

Group type: COMPARATOR
Intervention: No information sheet
Number of subjects: 322
Study: 33673371

Group type: EXPERIMENTAL
Intervention: Oral Sucrosomial Iron (SI) 60 mg/day for 8 weeks then 30 mg/day for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous Ferric Carboxy-Maltose (FCM) 1000 mg at baseline
Number of subjects: 0
Study: 35388626

Group type: COMPARATOR
Intervention: Conventional Ventilation (CV)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: High Frequency Oscillation (HFO)
Number of subjects: 319
Study: 32056766

Group type: EXPERIMENTAL
Intervention: Peer- or clinician-led group behavioral treatment for 20 weeks
Number of subjects: 323
Study: 36014767

Group type: EXPERIMENTAL
Intervention: Glucoraphanin from broccoli (BroccoMax®)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Alliin from garlic (Kwai Heartcare®)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no glucoraphanin or alliin supplements)
Number of subjects: 42
Study: 32352949

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-pharmacological methods
Number of subjects: 0
Study: 33211349

Group type: EXPERIMENTAL
Intervention: EMF exposure (50 Hz, 28 μT, linear polarized, continuous)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 34
Study: 32718787

Group type: EXPERIMENTAL
Intervention: Buddy taping
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cast immobilization
Number of subjects: 72
Study: 35526570

Group type: EXPERIMENTAL
Intervention: WATCHMAN FLX device
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Oral anticoagulation (control)
Number of subjects: 1600
Study: 33616652

Group type: EXPERIMENTAL
Intervention: Lenalidomide induction (15 mg orally on days 1-21)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Idarubicine‐cytarabine (cycle 1) and daunorubicin and intermediate‐dose cytarabine (cycle 2) without lenalidomide
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Maintenance with lenalidomide (10 mg on days 1-21)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Observation (control for maintenance phase)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Lenalidomide benefit suggested in SRSF2‐mutant AML (exploratory post hoc analysis)
Number of subjects: 780
Study: 32175901

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty (CHA)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty (UCH)
Number of subjects: 158
Study: 35193054

Group type: EXPERIMENTAL
Intervention: SCT630 (40 mg)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Adalimumab (40 mg)
Number of subjects: 146
Study: 34934969

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate plus prednisone (AAP)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: AAP with degarelix
Number of subjects: 122

Group type: COMPARATOR
Intervention: Degarelix
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: AAP
Number of subjects: 122
Study: 36240387

Group type: EXPERIMENTAL
Intervention: HOMA‐IR assessment in newborns HEU
Number of subjects: 450

Group type: COMPARATOR
Intervention: TDF/XTC/DTG in utero ARV exposure
Number of subjects: 450

Group type: COMPARATOR
Intervention: AZT postnatal prophylaxis
Number of subjects: 450
Study: 32000193

Group type: EXPERIMENTAL
Intervention: Video discharge instructions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard discharge instructions
Number of subjects: 60
Study: 34937456

Group type: EXPERIMENTAL
Intervention: Rewarded group (n = 19) trained with performance feedback and contingent monetary reward
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (n = 18) used the same system without monetary reward and with graphically minimized performance feedback
Number of subjects: 37
Study: 33619820

Group type: EXPERIMENTAL
Intervention: Cream applied with expectation of pain reduction after 5 minutes (P5)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cream applied with expectation of pain reduction after 30 minutes (P30)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cream with no analgesic expectation (NE)
Number of subjects: 53
Study: 32228074

Group type: EXPERIMENTAL
Intervention: Patellofemoral arthroplasty (PFA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 100
Study: 35134818

Group type: EXPERIMENTAL
Intervention: trans‐C16:1n‐7 in isolation
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: trans‐C16:1n‐7 combined with iso‐C17:0
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: C15:0 and C17:0
Number of subjects: 62
Study: 33722864

Group type: EXPERIMENTAL
Intervention: Direct angiosuite transfer (DAT)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard imaging/emergency department-based management
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: DAT
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 208
Study: 32344384

Group type: EXPERIMENTAL
Intervention: Automated LFCT measurement
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Older age (>69)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Body habitus
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Apnea/hypopnea duration, apnea vs. hypopnea, nadir O2 saturation, sleep stages (N vs. R)
Number of subjects: 596
Study: 36264299

Group type: EXPERIMENTAL
Intervention: blended problem-based learning (bPbL)
Number of subjects: 317

Group type: COMPARATOR
Intervention: conventional problem-based learning (cPbL)
Number of subjects: 317
Study: 33531255

Group type: COMPARATOR
Intervention: Testosterone undecanoate (TU) plus placebo (PL)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Testosterone undecanoate (TU) plus dutasteride (DT)
Number of subjects: 16
Study: 35811600

Group type: EXPERIMENTAL
Intervention: Peer-led preventive oral health education
Number of subjects: 372

Group type: COMPARATOR
Intervention: Class-based lecture on oral health (Control)
Number of subjects: 372
Study: 34057684

Group type: EXPERIMENTAL
Intervention: SEPTIN12 c.474 G > A polymorphism in teratozoospermic patients
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Non-smoking teratozoospermic patients
Number of subjects: 48

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fertile controls
Number of subjects: 48
Study: 34665856

Group type: EXPERIMENTAL
Intervention: Salbutamol (24 mg oral)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34959874

Group type: EXPERIMENTAL
Intervention: Whole-Body Electromyostimulation (WB-EMS)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RES)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cycling Endurance Exercise (END)
Number of subjects: 6
Study: 36008058

Group type: EXPERIMENTAL
Intervention: Slowly absorbable mesh
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (conventional care including primary closure, non-absorbable synthetic mesh or biologic mesh)
Number of subjects: 0
Study: 32326264

Group type: EXPERIMENTAL
Intervention: Stent-graft implantation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Prosthesis implantation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Group 1 (Prosthesis implantation)
Number of subjects: 38
Study: 35640529

Group type: EXPERIMENTAL
Intervention: 7.5 mg oral THC
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 15 mg oral THC
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 37092240

Group type: EXPERIMENTAL
Intervention: UVC
Number of subjects: 233

Group type: COMPARATOR
Intervention: PICC
Number of subjects: 233
Study: 33970290

Group type: EXPERIMENTAL
Intervention: SRX246
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32459035

Group type: EXPERIMENTAL
Intervention: 0.005% estriol vaginal gel
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 33887341

Group type: EXPERIMENTAL
Intervention: Thin-strut biodegradable polymer sirolimus-eluting stents (BP-SES)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stents (DP-EES)
Number of subjects: 145
Study: 33125166

Group type: EXPERIMENTAL
Intervention: External + Internal Facilitation (EF/IF)
Number of subjects: 43

Group type: COMPARATOR
Intervention: External Facilitation (EF)
Number of subjects: 43
Study: 33832035

Group type: EXPERIMENTAL
Intervention: Subpressure subgroup (after adhesives applied)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal pressure subgroup (after adhesives applied)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Subpressure subgroup
Number of subjects: 120
Study: 33308820

Group type: EXPERIMENTAL
Intervention: Compression Garments (CG)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control Garment (normal cloth)
Number of subjects: 8
Study: 34818660

Group type: EXPERIMENTAL
Intervention: SPC counselling
Number of subjects: 80

Group type: COMPARATOR
Intervention: Brochure with SPC counselling on demand
Number of subjects: 80
Study: 35319669

Group type: EXPERIMENTAL
Intervention: Antibiotic group (GAtb) - 500 mg amoxicillin + 400 mg metronidazole
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Probiotic group (GProb) - Lactobacillus reuteri
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study: 36478225

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study: 33429767

Group type: EXPERIMENTAL
Intervention: Early path nursing
Number of subjects: 0
Study: 33138740

Group type: EXPERIMENTAL
Intervention: Structured play-based life-skills intervention (biweekly games led by a coach for 30 minutes)
Number of subjects: 1752

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1752